English
BioVentrix, Inc.
EDGAR1 filing records in this dataset, filed from 2026-02-12 to 2026-02-12. Explore the available filing history and original sources.
Registration statement
This company has filed to register securities with the SEC and has not yet filed an annual or quarterly report. Its financial statements are in the filing itself rather than structured data, so reported figures appear here once periodic reports are filed.
- Registration statement (S-1) · filed 2026-02-12 Open filing documents
Offering terms · S-1 · 2026-02-12
- Security
- Common stock, par value $0.0001 per share(4)
- Maximum offering price
- USD 17,250,000
- Registration fee
- USD 2,382.23 · 0.0138%
- Security
- Representative's Warrants(4)(5)(6)
- Maximum offering price
- —
- Registration fee
- USD -0 · —
- Security
- Common stock, par value $0.0001 per share, issuable upon exercise of the Representative's Warrants(4)
- Maximum offering price
- USD 862,500
- Registration fee
- USD 119.12 · 0.0138%
The maximum offering price is the amount the registration fee is computed on, not what the company expects to raise. The offering size and price range are in the prospectus.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
1 filings · 0 latest values · 0 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001283259, 1283259, edgar:1283259
Also known as BIOVENTRIX INC, BIOVENTRIX, INC., BioVentrix, Inc., CHF TECHNOLOGIES INC